HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Finds Morphine-Spiked Herbal Cough Syrup In Chinese Firm's Plant

This article was originally published in The Tan Sheet

Executive Summary

The finding of morphine in a consumer health product made in China could rekindle concerns about lapses in supply chain security previously linked to drugs and adulterants or contaminants found in other imported FDA-regulated products.

You may also be interested in...



Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants

FDA says trace amounts of melamine found in U.S.-manufactured infant formula poses no danger, but the discovery will likely lead to a renewed push for food safety oversight and possibly for a separate food safety agency

Heparin Fallout Likely To Impact Supplement Ingredient Testing Exemptions

The discovery of adulterated ingredients in imported prescription drugs will likely cause increased scrutiny of supply chain operations for other segments across the food and drug industries

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain

Topics

UsernamePublicRestriction

Register

RS108770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel